Edition:
United Kingdom

Mallinckrodt Plc (MNK.N)

MNK.N on New York Stock Exchange

30.00USD
18 Sep 2018
Change (% chg)

$0.33 (+1.11%)
Prev Close
$29.67
Open
$29.79
Day's High
$30.07
Day's Low
$29.53
Volume
307,364
Avg. Vol
783,438
52-wk High
$39.05
52-wk Low
$11.66

Chart for

About

Mallinckrodt public limited company develops, manufactures, markets and distributes branded and generic specialty pharmaceutical products and therapies. The Company focuses on various therapeutic areas, such as autoimmune and rare disease specialty areas, including neurology, rheumatology, nephrology, ophthalmology and... (more)

Overall

Beta: 1.50
Market Cap(Mil.): $3,479.97
Shares Outstanding(Mil.): 97.18
Dividend: --
Yield (%): --

Financials

  MNK.N Industry Sector
P/E (TTM): -- 30.93 32.76
EPS (TTM): -0.15 -- --
ROI: -0.14 15.07 14.61
ROE: -0.39 16.59 16.33

UPDATE 2-Trump administration proposes production quota cuts for six opioids

WASHINGTON/NEW YORK, Aug 16 The Trump administration on Thursday proposed that U.S. drugmakers cut production quotas of the six most abused opioids by 10 percent next year to fight a nationwide addiction crisis.

16 Aug 2018

BRIEF-Mallinckrodt Reports Q1 Adjusted Earnings Per Share Of $1.31

* Q1 ADJUSTED LOSS PER SHARE $0.50 FROM CONTINUING OPERATIONS

08 May 2018

BRIEF-Mallinckrodt Reports On FDA Joint Advisory Committee Meeting For Stannsoporfin

* MALLINCKRODT REPORTS ON FDA JOINT ADVISORY COMMITTEE MEETING FOR STANNSOPORFIN FOR THE TREATMENT OF NEWBORNS AT RISK OF DEVELOPING SEVERE JAUNDICE

03 May 2018

BRIEF-Mallinckrodt Announces $300 Million Debt Repayment

* MALLINCKRODT PLC - COMPANY REPAYS DEBT MATURING APRIL 2018 WITH CASH ON HAND

16 Apr 2018

BRIEF-Mallinckrodt Names Paul Carter, Anne Whitaker To Its Board Of Directors

* MALLINCKRODT NAMES PAUL R. CARTER, ANNE C. WHITAKER TO ITS BOARD OF DIRECTORS

04 Apr 2018

BRIEF-Angus Russell To Succeed Melvin Booth As Mallinckrodt Board Chairman In May 2018

* ANGUS RUSSELL TO SUCCEED MELVIN BOOTH AS MALLINCKRODT CHAIRMAN OF THE BOARD IN MAY 2018

04 Apr 2018

BRIEF-Evoke Announces Agreement With Mallinckrodt To Amend Milestone Payments

* EVOKE ANNOUNCES AGREEMENT WITH MALLINCKRODT TO AMEND MILESTONE PAYMENTS

26 Mar 2018

Competitors

  Price Chg
Meda AB (MEDAa.ST) -- --
Merck KGaA (MRCG.DE) €87.44 +0.58
AB Science SA (ABS.PA) €4.08 -0.04

Earnings vs. Estimates